BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  GeoVax Issues Open Letter to HHS Secretary Alex Azar

  GeoVax Labs, Inc., a biotechnology company developing human vaccines, today published an open letter to U.S. Department of Health and Human Services Secretary Alex Azar in response to the HHS initiative “Ending the HIV Epidemic: A Plan for America.”

  February 14, 2019

   · 

  4 min read
• 

  Business

  Novartis’ Busy Day: 10-Target Deal With AbCellera and FDA Approves Parasite Drug

  Novartis announced that the FDA approved the company’s Egaten to treat fascioliasis in patients six years of age and older. Novartis also inked a multi-target and multi-year collaboration with AbCellera.

  February 14, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Merck Eyes Plans Phase III Programs in Prostate Cancer With Keytruda

  The pharma giant announced plans to expand its immuno-oncology program with three new Phase III trials following promising data from a combination of Keytruda and Lynparza and other agents.

  February 14, 2019

   · 

  3 min read

   · 

  Alex Keown
• Recipharm announces all its facilities are ready for EU serialisation

  Recipharm announced that all fifteen of its facilities outlined in its investment plan are now fully prepared for drug serialisation and have delivered serialised batches within Europe ahead of the February 9th deadline.

  February 14, 2019

   · 

  2 min read
• BIO-Europe Spring® comes to Vienna for Europe’s most important springtime life science partnering event

  The thirteenth annual BIO-Europe Spring®international partnering conference meets in Vienna, Austria, March 25–27, 2019, at the Messe Wien Exhibition and Congress Center.

  February 14, 2019

   · 

  3 min read
• 

  Job Trends

  Axovant Launches Arvelle Therapeutics to Commercialize Epilepsy Drug

  Axovant Sciences, one of Vivek Ramaswamy’s biotech companies under the Roivant Sciences’ umbrella, is forming a company called Arvelle Therapeutics. Arvelle is a strategic transition of Axovant’s legacy small molecule team.Biopharmaceuticals

  February 14, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Job Trends

  BioSpace Movers and Shakers: Feb. 15

  Pharma and biotech companies strengthen their leadership teams with new hires and appointments at Cadent, bluebird, Abeona, Sanofi, and more.

  February 14, 2019

   · 

  5 min read

   · 

  Alex Keown
• Blindfolded training could help doctors save young lives

  Doctors’ leadership in pediatric resuscitation improved most when they wore a blindfold during simulation training

  February 14, 2019

   · 

  3 min read
• Fujitsu Launches “Healthcare Personal service Platform” to Manage Health and Medical Information

  Strongly supporting companies and regional authorities that seek to provide new services for healthy, more fulfilling lifestyles

  February 14, 2019

   · 

  6 min read
• Business

  MDxHealth (R): MDxHealth Signs Partnership with LifeLabs to Make SelectMDx available in Canada

  MDxHealth SA announces that it has signed an exclusive distribution agreement with LifeLabs to make SelectMDx®, the Company’s non-invasive liquid biopsy prostate cancer test, available in Canada.

  February 14, 2019

   · 

  5 min read